Clinical trials
Completed Atherosclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
882 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 25 |
| 2001 | 27 |
| 2002 | 16 |
| 2003 | 41 |
| 2004 | 33 |
| 2005 | 26 |
| 2006 | 40 |
| 2007 | 54 |
| 2008 | 52 |
| 2009 | 47 |
| 2010 | 35 |
| 2011 | 35 |
| 2012 | 35 |
| 2013 | 27 |
| 2014 | 44 |
| 2015 | 35 |
| 2016 | 42 |
| 2017 | 35 |
| 2018 | 28 |
| 2019 | 20 |
| 2020 | 23 |
| 2021 | 26 |
| 2022 | 21 |
| 2023 | 16 |
| 2024 | 14 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 882 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 82 |
| GlaxoSmithKline | 32 |
| Boston Scientific Corporation | 19 |
| AstraZeneca | 14 |
| Korea University | 12 |
| Massachusetts General Hospital | 11 |
| Novartis Pharmaceuticals | 11 |
| Organon and Co | 11 |
| University of Washington | 10 |
| Johns Hopkins University | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 882 |
| Cardiovascular Diseases | 235 |
| Coronary Artery Disease | 137 |
| Heart Diseases | 116 |
| Coronary Disease | 88 |
| Inflammation | 67 |
| Diabetes Mellitus | 60 |
| Hypercholesterolemia | 55 |
| Peripheral Arterial Disease | 54 |
| Myocardial Infarction | 47 |
Trials
Showing 1 to 25 of 882. Each trial links to its page on Pharma Observatory.
782 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.